AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+2.75%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.17B
AUM Growth
+$2.17B
(+3.9%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
7.14%
Top 10 Holdings %
Top 10 Hldgs %
58.3%
Holding
120
New
20
Increased
21
Reduced
32
Closed
19
Top Buys
| 1 |
Avantor
AVTR
|
$134M |
| 2 |
Zillow
Z
|
$41.8M |
| 3 |
Uber
UBER
|
$23.2M |
| 4 |
Cyclerion Therapeutics
CYCN
|
$15.6M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$11M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$48.8M |
| 2 |
InflaRx
IFRX
|
$31.2M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$11M |
| 4 |
Wave Life Sciences
WVE
|
$9.71M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$9.43M |
Sector Composition
| 1 | Healthcare | 72.1% |
| 2 | Consumer Discretionary | 17.9% |
| 3 | Technology | 5.46% |
| 4 | Communication Services | 2.13% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lexicon Pharmaceuticals
LXRX
$400M
| $379M | 15.32% | 60,240,864 | – | – |
|
|
WW
2
DELISTED
WW International
WW
| $283M | 11.45% | 14,818,300 | – | – |
|
|
3
Avantor
AVTR
$9.18B
| $134M | 5.4% | +7,000,000 | New | +$134M |
|
|
ONC
4
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $80.6M | 3.26% | 650,000 +50,000 | +8% | +$6.2M |
|
5
Alibaba
BABA
$322B
| $76.3M | 3.08% | 450,000 +38,000 | +9% | +$6.44M |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $70.7M | 2.86% | 750,000 -100,000 | -12% | -$9.43M |
|
7
NVIDIA
NVDA
$4.24T
| $69M | 2.79% | 420,000 | – | – |
|
8
Moderna
MRNA
$9.37B
| $67.4M | 2.73% | 4,606,298 -400,000 | -8% | -$5.86M |
|
|
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
| $61.6M | 2.49% | 1,500,000 -150,000 | -9% | -$6.16M |
|
|
10
Zillow
Z
$20.4B
| $46.4M | 1.88% | 1,000,000 +900,000 | +900% | +$41.8M |
|
|
RUBY
11
DELISTED
Rubius Therapeutics, Inc
RUBY
| $44.6M | 1.8% | 2,833,791 -75,000 | -3% | -$1.18M |
|
12
Scholar Rock
SRRK
$3.14B
| $37.2M | 1.5% | 2,346,040 | – | – |
|
|
MDCO
13
DELISTED
Medicines Co
MDCO
| $36.5M | 1.48% | 1,000,000 +300,000 | +43% | +$10.9M |
|
14
Gossamer Bio
GOSS
$562M
| $35.7M | 1.44% | 1,608,968 -50,000 | -3% | -$1.11M |
|
15
Amicus Therapeutics
FOLD
$2.34B
| $31.2M | 1.26% | 2,500,000 -100,000 | -4% | -$1.25M |
|
16
argenx
ARGX
$43.6B
| $31.1M | 1.26% | 220,000 +20,000 | +10% | +$2.83M |
|
17
Fate Therapeutics
FATE
$120M
| $30.5M | 1.23% | 1,500,000 -300,000 | -17% | -$6.09M |
|
18
Alnylam Pharmaceuticals
ALNY
$58.5B
| $29M | 1.17% | 400,000 -50,000 | -11% | -$3.63M |
|
|
SAGE
19
DELISTED
Sage Therapeutics
SAGE
| $27.5M | 1.11% | 150,000 +25,000 | +20% | +$4.58M |
|
20
Agios Pharmaceuticals
AGIO
$2.19B
| $24.9M | 1.01% | 500,000 +100,000 | +25% | +$4.99M |
|
21
Nektar Therapeutics
NKTR
$568M
| $24.9M | 1.01% | 700,000 -200,000 | -22% | -$7.12M |
|
|
22
Uber
UBER
$196B
| $23.2M | 0.94% | +500,000 | New | +$23.2M |
|
23
Atara Biotherapeutics
ATRA
$84.6M
| $23.1M | 0.94% | 1,150,000 | – | – |
|
|
EPZM
24
DELISTED
Epizyme, Inc
EPZM
| $20.7M | 0.84% | 1,650,000 -100,000 | -6% | -$1.26M |
|
25
Ascendis Pharma
ASND
$11.8B
| $17.3M | 0.7% | 150,000 +25,000 | +20% | +$2.88M |
|